UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of April, 2013.
Commission File Number ________________
Novogen Limited
(Translation of registrants name into English)
1-7 Waterloo Road, Macquarie Park, NSW, Australia
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F o |
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o
Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o
Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrants home country), or under the rules of the home country exchange on which the registrants securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrants security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.
Indicate by check mark if the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes o No x
If yes is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Novogen Limited (Registrant)
(Signature) *
Andrew Bursill
Date 11 April 2013
* Print the name and title under the signature of the signing officer.
*** VIA EMAIL ***
11 April 2013
Elvis Onyura
Adviser, Listings (Sydney)
ASX Compliance Pty Ltd
20 Bridge Street
Sydney NSW 2000
By email: elvis.onyura@asx.com.au
Dear Mr Onyura
Trading Halt Request
NOVOGEN LIMITED ACN 063 259 754 (the Company)
The Company requests a trading halt of its securities with effect from prior to commencement
of trading on 11 April 2013.
The trading halt is requested pending an announcement by the Company in relation to a
proposed material capital raising.
It is requested that the trading halt remain in place until the earlier of open of trade on 15 April
2013 or release of an announcement by the Company regarding the proposed capital raising.
The Company has also requested a trading halt for the Companys ADRs trading on the
NASDAQ from prior to the commencement of trading on 11 April 2013 (US Eastern time),
with trading to resume on 15 April 2013 (US Eastern time).
The Company is not aware of any reason why the trading halt should not be granted.
For and on behalf of the Board
Andrew Bursill
Company Secretary
NOVOGEN LIMITED
ABN 37 063 259 754
Level 1, 1-7 Waterloo Road
North Ryde NSW 2113